The current valuation score of Bicycle Therapeutics PLC is 7.85, ranking 192 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.26, which is 0.00% below the recent high of -1.26 and -566.70% above the recent low of -8.41.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.